Scientific work

Prof. Dr. Johan Joseph Marıa Catharına Hubertus Delarosette

707 publications. The source of the information is stated next to each publication.

Back to profile

  1. J.J.M.C.H. de la Rosette, G.Alivizatos, S. Madersbacher, M. Perachino, D. Thomas, F. Desgrandchamps, M. de Wildt. EAU Guidelines on Benign Prostatic Hyperplasia (BPH). Eur Urol 2001; (40): 256-263.

    Source: medipol.com.tr profile page

  2. Y. Xue, G. Sonke, C. Schoots, J. Schalken, A. Verhofstad, J.J.M.C.H. de la Rosette, F. Smedts. Proliferative activity and branching morphogenesis in the human prostate: a closer look at pre- and postnatal prostate growth. The Prostate 2001; (49): 132-139.

    Source: medipol.com.tr profile page

  3. J.J.M.C.H. de la Rosette. Introduction. Eur Urol 2001; 40(1).

    Source: medipol.com.tr profile page

  4. A.L. Hoffmann, J.J.M.C.H. de la Rosette, H. Wijkstra. Intraprostatic temperature monitoring during transurethral microwave thermotherapy: status and future developments. J Endourol 2001; 14(8): 637-642.

    Source: medipol.com.tr profile page

  5. D.L. Floratos, J.J.M.C.H. de la Rosette. The future role of microwave therapy in benign prostatic hyperplasia. Urol Integr Invest 2001; (6-3): 215-223.

    Source: medipol.com.tr profile page

  6. M.P. Laguna, L.A. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy. J Urol 2002: 1727-1730.

    Source: medipol.com.tr profile page

  7. G.S. Sonke, C. Robertson, A.L.M. Verbeek, W.P.J Witjes, J.J.M.C.H. de la Rosette, A method for estimating within-patient variability in maximum urinary flow rate adjusted for voided volume. Urology 2002; (59-3): 368-372.

    Source: medipol.com.tr profile page

  8. J.J.M.C.H. de la Rosette, B.B.M. Kortman, C. Rossi, G.S. Sonke, D.L. Floratos, L.A.L.M. Kiemeney. Long-term risk of retreatment in patients using alpha-blockers for lower urinary tract symptoms. J Urol 2002; (167): 1734-1739.

    Source: medipol.com.tr profile page

  9. J. Eckersley, J.P.M. Sedelaar, M.J. Blomley, H. Wijkstra, N.M. DeSouza, D.O. Cosgrove, J.J.M.C.H. de la Rosette. Quantitative microbubble enhanced transrectal ultrasound as tool for monitoring hormonal treatment of prostate cancer. Prostate june 2002 51(4): 256-267.

    Source: medipol.com.tr profile page

  10. J.J.M.C.H. de la Rosette, D.K.E. van der Schoot, F.M.J. Debruyne. Recent developments in guidelines on benign prostatic hyperplasia. Current Opinion in Urology 2002; (12): 3-6.

    Source: medipol.com.tr profile page

  11. J.J.C.M.H. de la Rosette F. Smedts, C. Schoots, H. Hoek, P. Laguna. Changing patterns of keratin expression characterize functional maturation in developing human bladder. J Urol 2002; 168(2): 709-717.

    Source: medipol.com.tr profile page

  12. W.P.J. Witjes, J.J.M.C.H. de la Rosette, A. van den Berg-Segers, D. Colongo, G. Koch, A.R. Zlotta, A. Colau, M.J.A.M. de Wildt, H. Wijkstra. Computerised assessment of maximum urinary flow: an efficient, consistent and valid approach. Eur Urol 2002 41(2): 206-213.

    Source: medipol.com.tr profile page

  13. B. Djavan, J.C. Nickel, J.J.M.C.H. de la Rosette, P. Abrams. The Urologist view of BPH progression: Results of an international survey. Eur. Urol 2002; 41(5): 490-496.

    Source: medipol.com.tr profile page

  14. J.J.M.C.H. de la Rosette, C.C. Abbou, J. Rassweiler, M.P. Laguna, CC. Schulman. Laparoscopic radical prostatectomy: a European virus with global potentials. Arch. Esp. Urol. 2002; 55(6): 603-609.

    Source: medipol.com.tr profile page

  15. P.C. Soeverein, R.M.C. Herings, A.J. Man in ‘t Veld, J.J.M.C.H. de la Rosette, R.D.T. Farmer, H.G.M. Leufkens. Study of the association between ischemic heart disease and use of alpha-blockers and finasteride indicated for the treatment of benign prostatic hyperplasia. Eur. Urol. 2002; 42: 254-261.

    Source: medipol.com.tr profile page

  16. J. Veltman, T. Goossen, M.P. Laguna, H. Wijkstra, J.J.M.C.H. de la Rosette. New technical improvements for TRUS in diagnosis of prostate cancer. Eur Urol. Supplements 1; 2002; 1(6): 8-14.

    Source: medipol.com.tr profile page

  17. J. Vanderkerken, J.J.M.C.H. de la Rosette, M.P. Laguna, F.M.J. Debruyne. How and when to take prostate biopsies. Eur. Urol. Supplements 1; 2002; 1(6): 15-20.

    Source: medipol.com.tr profile page

  18. J.P.M. Sedelaar, G.J.L.H. van Leenders, T.E.B. Goossens, C.A. Hulsbergen-van der Kaa, N.P. van Adrichem, H. Wijkstra, J.J.M.C.H. de la Rosette. The value of contrast ultrasonography in the detection of significant prostate cancer: correlation with radical prostatectomy specimens. Prostate 2002; 53: 246-253.

    Source: medipol.com.tr profile page

  19. P.C. Souverein, R.M.C. Herings, J.A. Erkens, J.J.M.C.H. de la Rosette, H.G.M. Leufkes, H.G.M. Leufkens. Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery. Eur Urol. 2003; 43: 528-534.

    Source: medipol.com.tr profile page

  20. A.L. Hoffmann, M.P. Laguna, J.J.M.C.H. de la Rosette, H. Wijkstra. Quantification of Prostate shrinkage after microwave thermotherapy: a comparison of calculated cell-kill versus 3D transrectal ultrasound planimetry. Eur. Urol. 2003; 181-187.

    Source: medipol.com.tr profile page

  21. M. Emberton, G. Andriole, J.J.C.M.H. de la Rosette, B. Djavan, K. Hofner, V. Navarrete, J. Nordling, C. Roehrborn, C. Schulman, P. Teillac, A. Tubaro, C. Nickel. BPH: A progressive disease of the ageing male. Urology. 2003; 61: 267-273.

    Source: medipol.com.tr profile page

  22. S. Gravas, M.P. Laguna, J.J.M.C.H. de la Rosette. Thermotherapy and thermoablation for BPH. Curr. Opnion Urol. 2003; 13: 45-49.

    Source: medipol.com.tr profile page

  23. J.J.M.C.H. de la Rosette, M.P. Laguna, S.Gravas, M.J.A.M. de Wildt. Transurethral Microwave Thermotherapy: the 'gold standard' for minimal invasive therapies in patients with Benign prostatic Hyperplasia (BPH). J. Endourol 2003; 4: 245- 251

    Source: medipol.com.tr profile page

  24. M.G. Harisinghani, J. Barentsz, P.F. Hahn, W.M. Deserno, S. Tabatabaei, C.H. van der Kaa., J.J.M.C.H. de la Rosette, R. Weissleder. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003; 348(25):2491-9.

    Source: medipol.com.tr profile page

  25. S. Gravas, M.P. Laguna, P.J. van Hest, J.J.M.C.H. de la Rosette. Efficacy and safety of intraprostatic temperature controlled microwave thermotherapy in patients with benign prostatic hyperplasia: Results of a porspective, open label, single center study with 1-year follow up. J. Endourol. 2003; 17: 425-430.

    Source: medipol.com.tr profile page

  26. T.M. de Reijke, H.P. Beerlage, A.J. Hendrikx, J.J.M.C.H. de la Rosette, C.A. Mc.Killop. Prostate cancer: the right treatment for the right patient. Amsterdam 17 -18 Januari 2001. Prostate Cancer Prostatic Dis. 2003; 6(2): 193-197.

    Source: medipol.com.tr profile page

  27. B.W. Lagerveld, M.P. Laguna, J.J.M.C.H. de la Rosette. Long-term results after extrernal beam radiation therapy for T1-T2 localixes prostate cancer. Curr. Urol. Rep. 2003; 4:240-247.

    Source: medipol.com.tr profile page

  28. D.L. Floratos, M.P. Laguna, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J. M.C.H. de la Rosette. Transurethral Resection versus Microwave Thermotherapy of the Prostate. A Cost-Consequences Analysis. BJU 2003; 92: 713-718.

    Source: medipol.com.tr profile page

  29. C.A. Mochtar, L.A.L.M. Kiemeney, M.M. van Riemsdijk, G.S. Barnet, M.P. Laguna, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. PSA as an estimator of prostate volume in the management of patients with symptomatic BPH. Eur. Urol. 2003; 44: 65-700.

    Source: medipol.com.tr profile page

  30. B.B.M. Kortmann, D.L. Floratos, L.A.L.M. Kiemeney, H. Wijkstra, J.J.M.C.H. de la Rosette. Urodynamic Effects of Alpha-Adrenoceptor Blockers: A Review of Clinical Trials. Urology 2003; 62:1-9.

    Source: medipol.com.tr profile page

  31. T.E.B. Goossen, J.J.M.C.H. de la Rosette, C.A. Hulsbergen-van de Kaa, H. Wijkstra. The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. Eur Urol 2003. 43(2): 124-131.

    Source: medipol.com.tr profile page

  32. M.R. Engelbrecht, H.J. Huisman, R.J.R. Laheij, G.J. Jager, G.J.L.H. van Leenders, C.A. Hulsbergen-van de Kaa, J.J.M.C.H. de la Rosette, J.G. Blickman, J.O. Barentsz. Discrimination of prostate cancer from peripheral zone and central zone gland tissue using dynamic contrast-enhanced MR imaging. Radiology. 2003. 229(1): 248-54.

    Source: medipol.com.tr profile page

  33. J.P.M. Sedelaar, J.J.M.C.H. de la Rosette, F.M.J. Debruyne. Progress in imaging of the prostate gland. Curr Urol Rep. 2003. 4(1):1-2.

    Source: medipol.com.tr profile page

  34. M. Marberger., R. Harkaway, J.J.M.C.H. de la Rosette. Optimising the medical management of BPH. Eur. Urol. 2004; 45: 411-419.

    Source: medipol.com.tr profile page

  35. C. Huidobro, M. Bolmsjö, T. Larson, J.J.M.C.H. de la Rosette, L. Wagrell, S. Schelin, T. Gorecki, A. Mattiasson. Evaluation of Prostalund coretherm microwave theromotherapy with histo-pathology, MRI and temperature mapping. J.Urol. 2004; 171:672-678.

    Source: medipol.com.tr profile page

  36. T. Horn, B.B. Kortmann, F. Smedts, J. Nordling, L.A. Kiemeney, J.J.M.C.H. de la Rosette. Routine bladder biopties in men with bladder outlet obstruction? Urol. 2004; 63(3): 451-456.

    Source: medipol.com.tr profile page

  37. F.A. van Dorsten, M. van der Graaf, M.R. Engelbrecht, A. Verhofstad, A. van Leenders, M. Rijpkema, J.J.M.C.H. de la Rosette, J.O. Barentz, Heerschap. Combined quantitative dynamic contrast-enhanced MR imaging and (1)-H MR spectroscopic imaging of human prostate cancer. J. Magn Reson Imaging. 2004; 20(2): 279-287.

    Source: medipol.com.tr profile page

  38. C. Roehrborn, J.J.M.C.H. de la Rosette, G. Andriole. The utility of serial PSA measurements for the diagnosis of prostate cancer is preserved in men treated with the dual 5α-reductase inhibitor dutasteride.

    Source: medipol.com.tr profile page

  39. M.C. Michel, J.J.M.C.H. de la Rosette. Efficacy and safety of tamsulosin in the treatment of urological diseases. Ashley Pub. Expert opinion Pharmacother. 2004; 5:1-10.

    Source: medipol.com.tr profile page

  40. N. Naderi, C.A. Mochtar, J.J.M.C.H. de la Rosette. Real life practice in the management op BPH. Curr. Opin Urol 2004; 14: 41-44.

    Source: medipol.com.tr profile page

  41. P. Bhowmick, J.E. Coad, S Bhowmick, J.L. Pryor, T. Larson, J.J.M.C.H. de la Rosette, J.C. Bischof. In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia. Int. J. Hyperthermia. 2004; 20(4): 421-439.

    Source: medipol.com.tr profile page

  42. F.A. van Dorsten, M. van der Graaf, M.R. Engelbrecht, G.J. van Leenders, A. Verhofstad, M. Rijpkema, J.J.M.C.H. de la Rosette, J.O. Barentsz, A. Heerschap. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging. 2004 Aug;20(2):279-87.

    Source: medipol.com.tr profile page

  43. S. Madersbacher, G. Alivizatos, J. Nordling, C.R. Sanz, M. Emberton, J.J.M.C.H. de la Rosette. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol. 2004 Nov;46(5):547-54.

    Source: medipol.com.tr profile page

  44. M.C. Michel, J.J.M.C.H. de la Rosette, M. Piro, M. Goepel. Does concomitant stress incontinence alter the efficacy of tolterodine in patients with overactive bladder? J Urol. 2004 Aug;172(2):601-4.

    Source: medipol.com.tr profile page

  45. H. Wijkstra, M.H. Wink, J.J.M.C.H. de la Rosette. Contrast specific imaging in the detection and localization of prostate cancer. World J Urol. 2004; Oct 5.

    Source: medipol.com.tr profile page

  46. P. Boyle, C. Roehrborn, R. Harkaway, J. Logie, J.J.M.C.H. de la Rosette, M. Emberton. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery. Eur Urol. 2004 May; 45(5):620-6; discussion 626-7

    Source: medipol.com.tr profile page

  47. M. Oelke, J.J.M.C.H. de la Rosette, M.C. Michel, U. Jonas. Medical therapy of urinary incontinence. Internist (Berl). 2004; Dec 18.

    Source: medipol.com.tr profile page

  48. P. Boyle, C. Roehrborn, R. Harkaway, J. Logie, J.J.M.C.H. de la Rosette, M.Emberton. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery. Eur Urol. 2004 May; 45(5):620-6; discussion 626-7.

    Source: medipol.com.tr profile page

  49. A. Skolarikos, G. Alivizatos, J.J.M.C.H. de la Rosette. Percutaneous nephrolithotomy and its legacy. Eur. Urol. 2005; 47: 22-28

    Source: medipol.com.tr profile page

  50. M.P. Laguna, L.C. Schreuders, J.J. Rassweiler, C.C. Abbou, R. van Velthoven, G. Janetschek, G. Breda, J.J.M.C.H. de la Rosette. Development of laparoscopic surgery ans training facilities in Europe: Results of a survey of the ESUT. Eur. Urol. 2005; 47: 346-351.

    Source: medipol.com.tr profile page